Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback